Experienced in Peripheral T-Cell Lymphoma

Marion Wobser

Josef Schneider Str. 2, 
Wuerzburg, BY, DE 
Experienced in Peripheral T-Cell Lymphoma
Josef Schneider Str. 2, 
Wuerzburg, BY, DE 
OverviewLocationsClinical Research

Overview

Marion Wobser practices in Wuerzburg, Germany. Wobser is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Non-Hodgkin Lymphoma.

Their clinical research consists of co-authoring 109 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Peripheral T-Cell Lymphoma.

Locations

Josef Schneider Str. 2, Wuerzburg, BY 97080, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II, Open-label, Randomized-controlled Trial Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody Atezolizumab for the Treatment in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
A Phase II, Open-label, Randomized-controlled Trial Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody Atezolizumab for the Treatment in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
Enrollment Status: Completed
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drugs: Vemurafenib, Cobimetinib, Atezolizumab
Study Phase: Phase 2

109 Total Publications

Mogamulizumab-associated rash and lymphocytopenia coinciding with treatment response of Sézary syndrome.
Mogamulizumab-associated rash and lymphocytopenia coinciding with treatment response of Sézary syndrome.
Journal: European journal of dermatology : EJD
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wobser's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile